Table 3.
Risk Factors for Prolonged Opioid Use after Lumbar Fusion.
Odds ratio [95%CI], P-value | ||
---|---|---|
Baseline demographics | BMI >35 | .44 [.20, .90], .03* |
Smoking: Never Current Former |
Ref 2.73 [1.14, 6.96], .03* 0.86 [.46, 1.58], .63 |
|
Insurance Status Medicare Private/Other |
Ref 1.43 [.85, 2.42], .18 |
|
Preoperative opioid consumption | Opioid preoperative Use: Non-chronic Chronic |
Ref 0.38 [.08, 1.52], .18 |
Max. Distance travelled | 1.01 [.99,1.05], .30 | |
Total # of prescriptions | .98 [.92, 1.05], .69 | |
Total # of prescribers | 1.14 [.90, 1.45], .28 | |
Duration of usage (days) | 1.00 [1.00, 1.01], .25 | |
# Of pills and/or tablets | 1.00 [1.00,1.00], .94 | |
Total # of pharmacies | .83 [.53, 1.27], .40 | |
Daily dose (MME) | 1.00 [1.00, 1.01], .40 |
Multivariable logistic regression model for predicting prolonged opioid consumption after lumbar fusion in relation to preoperative baseline characteristics. *Indicates statistical significance (P<.05).